PHI with Ankylosing spondylitis
How does this condition affect your private health insurance?
Bechterewsche Krankheit, also known as Ankylosing Spondylitis (AS), is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. It leads to persistent pain and stiffness, particularly in the lower back, hips, and buttocks, often worsening with rest and improving with activity. Over time, inflammation can cause new bone formation, leading to spinal fusion (ankylosis), resulting in a rigid, inflexible spine and a hunched posture. AS can also affect other joints and organs, including the eyes (uveitis), bowels (IBD), and heart. Early diagnosis and treatment are crucial to manage symptoms, slow disease progression, and preserve mobility and quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months (insidious onset of symptoms)
Duration of Illness (Lifetime)
Chronic, lifelong disease
Cost of Treatment (Initial)
Moderate to high (diagnosis, imaging, initial medications like NSAIDs, physical therapy)
Cost of Treatment (Lifetime)
High (chronic medication, often biologics; physical therapy, specialist visits, potential surgeries)
Mortality Rate
Low directly from the disease itself, but slightly increased cardiovascular risk and complications can impact life expectancy.
Risk of Secondary Damages
High (spinal fusion, severe pain, loss of mobility, uveitis, inflammatory bowel disease, psoriasis, cardiovascular issues, cauda equina syndrome)
Probability of Full Recovery
Very low (no cure, chronic condition; remission and effective management are possible)
Underlying Disease Risk
Moderate (associated with other autoimmune/inflammatory conditions such as uveitis, inflammatory bowel disease, and psoriasis)